Basic and clinical studies asociated with hepatic reticulo endothelial system after major surgery

大手术后肝网状内皮系统的基础与临床研究

基本信息

  • 批准号:
    08671432
  • 负责人:
  • 金额:
    $ 1.6万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1997
  • 项目状态:
    已结题

项目摘要

A stable hemorrhagic shock-resuscitation model of experimental animals for the basic study of severe infection (sepsis) or hepatic failure was established. The process of each organ dysfunction were studied and the hepatic reticuloendothelial function was objectively evaluated using our model. In this model, the evidence of systemic inflammatory response syndrome which is closely associated with multiple organ failure known as ultimate organ injury and terminal stage of sepsis were obtained, indicating that this shock model is useful to simulate sepsis and organ failure. especially hepatic failure. We also demonstrated that the organ injury. Especially hepatic failure, were associated with microcirculatory insufficiency and the accumulation of inflammatory cells (e.g. neutrophils). We, therefore, concluded that the blockage against these factors was likely to the important key for the treatment of the organ injury. The hepatic reticuloendothelial function is conceptually major host defense system to the bacterial infection such as E.coli infection and we partly elucidated the precise mechanisms of this immune response in the liver. Additionally, we elucidated that nitric oxide (NO). which is strong vaso-dilator regulating the organic microcirculation to protect from organ damages, is to be involved in bacterial killing in the liver. Whereas. 140 are recognized to have the effect of cellular injury. Therefore, regulation of selective NO synthetase would be expected to prevent hepatic dysfunction after major operation.
建立了一种稳定的失血性休克复苏实验动物模型,用于严重感染(败血症)或肝功能衰竭的基础研究。研究各脏器功能障碍的过程,并用该模型客观评价肝脏网状内皮功能。在该模型中,获得了与多器官衰竭密切相关的全身炎症反应综合征的证据,即终末期器官损伤和终末期脓毒症,表明该休克模型对模拟脓毒症和器官衰竭是有用的。尤其是肝功能衰竭。我们还证明了器官损伤。尤其是肝功能衰竭,与微循环功能不全和炎性细胞(如中性粒细胞)聚集有关。因此,我们得出结论,阻断这些因素可能是治疗器官损伤的重要关键。从概念上讲,肝脏网状内皮功能是对细菌感染(如大肠杆菌感染)的主要宿主防御系统,我们部分阐明了这种免疫反应在肝脏中的确切机制。此外,我们还阐明了一氧化氮(NO)。它是一种强大的血管扩张剂,调节有机微循环,保护器官免受损害,参与肝脏细菌的杀灭。然而。140被认为具有细胞损伤的作用。因此,选择性一氧化氮合酶的调节有望预防大手术后的肝功能障碍。

项目成果

期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takeuchi E: "Human hepatocyte growth factor in bile : An indicator of posthepatectomy liver function in patients with biliary tract carcinoma" Hepatology. 26. 1092-1099 (1997)
Takeuchi E:“胆汁中的人肝细胞生长因子:胆道癌患者肝切除术后肝功能的指标”肝病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Aono K: "In vitro and in vivo expression of inducible nitric oxide synthase during experimental endotoxemia: Involvement of other cytokines" J Cellular Biochemistry. 65. 349-358 (1997)
Aono K:“实验性内毒素血症期间诱导型一氧化氮合酶的体外和体内表达:其他细胞因子的参与”《细胞生物化学》杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Uesaka K,Nimura Y, et al.: "Changes in hepatic lobar function after right portal vein embolization:An appraisal by biliary indocyanine green excretion." Annals of Surgery. 223. 77-83 (1996)
Uesaka K、Nimura Y 等人:“右门静脉栓塞术后肝叶功能的变化:通过胆汁吲哚菁绿排泄进行评估。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Aono K: "In vitro and in vivo expression of inducible nitric oxide synthase during experimental endotoxemia. Involvement of other cytokines" J Cellular Biochemistry. 65. 349-358 (1997)
Aono K:“实验性内毒素血症期间诱导型一氧化氮合酶的体外和体内表达。其他细胞因子的参与”《细胞生物化学》杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nimura Y,Hayakawa N, et al.: "Hilar cholangiocarcinoma-Surgical anatomy and curative resection" Journal of Hepato-Biliary-Pancreatic Surgery. 2. 239-248 (1995)
Nimura Y,Hayakawa N,等人:“肝门部胆管癌-手术解剖学和治愈性切除”《肝胆胰外科杂志》。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NIMURA Yuji其他文献

NIMURA Yuji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NIMURA Yuji', 18)}}的其他基金

Comprehensive cancer therapy targeted Nek2 and translational research
针对 Nek2 的综合癌症治疗和转化研究
  • 批准号:
    20249062
  • 财政年份:
    2008
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
The Profiling of Cholangiocarcinoma and the Development of Molecular targeted therapy
胆管癌的概况和分子靶向治疗的发展
  • 批准号:
    16209039
  • 财政年份:
    2004
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
New vector system for the gene therapy of abdominal cancers.
用于腹部癌症基因治疗的新载体系统。
  • 批准号:
    09557103
  • 财政年份:
    1997
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Experomental and clinical studies to increase curability and safety of surgery for hilar cholangiocarcinoma
提高肝门部胆管癌手术治愈率和安全性的实验和临床研究
  • 批准号:
    04404050
  • 财政年份:
    1992
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (A)

相似海外基金

Regulation of HNF4 in Hepatic Failure in Cirrhosis
HNF4 在肝硬化肝衰竭中的调控
  • 批准号:
    9084549
  • 财政年份:
    2013
  • 资助金额:
    $ 1.6万
  • 项目类别:
Regulation of HNF4 in Hepatic Failure in Cirrhosis
HNF4 在肝硬化肝衰竭中的调控
  • 批准号:
    8892178
  • 财政年份:
    2013
  • 资助金额:
    $ 1.6万
  • 项目类别:
Regulation of HNF4 in Hepatic Failure in Cirrhosis
HNF4 在肝硬化肝衰竭中的调控
  • 批准号:
    8698412
  • 财政年份:
    2013
  • 资助金额:
    $ 1.6万
  • 项目类别:
Regulation of HNF4 in Hepatic Failure in Cirrhosis
HNF4 在肝硬化肝衰竭中的调控
  • 批准号:
    8560395
  • 财政年份:
    2013
  • 资助金额:
    $ 1.6万
  • 项目类别:
Nrf2 is a novel marker of oxidative stress at acute hepatic failure.
Nrf2 是急性肝衰竭时氧化应激的新标志物。
  • 批准号:
    24592735
  • 财政年份:
    2012
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Establishment of cell transplantation therapy for hepatic failure by hepatic stem/progenitor cells and/or hepatic organoids
建立肝干/祖细胞和/或肝类器官治疗肝衰竭的细胞移植疗法
  • 批准号:
    24390304
  • 财政年份:
    2012
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Higher serum methionine levels as a predictive factor in patients with irreversible fulminant hepatic failure
较高的血清蛋氨酸水平是不可逆暴发性肝衰竭患者的预测因素
  • 批准号:
    22591397
  • 财政年份:
    2010
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Application of SELDI ProteinChip system in pathogenesis of pediatric fulminamt hepatic failure
SELDI ProteinChip系统在小儿暴发性肝衰竭发病机制中的应用
  • 批准号:
    21591403
  • 财政年份:
    2009
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of regenerative medicine and therapeutic system for hepatic failure applied by hepatocyte nuclear factor 4
肝细胞核因子4应用于肝衰竭的再生医学及治疗体系的开发
  • 批准号:
    20590770
  • 财政年份:
    2008
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of prophylactic therapy against sepsis and hepatic failure in rat short bowel models managed with total parenteral nutrition
全肠外营养大鼠短肠模型脓毒症和肝衰竭预防性治疗的进展
  • 批准号:
    20890195
  • 财政年份:
    2008
  • 资助金额:
    $ 1.6万
  • 项目类别:
    Grant-in-Aid for Young Scientists (Start-up)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了